参芪壮骨丸治疗骨质疏松症的临床分析

Clinical Analytical Study for the Treatment of Osteoporosis by Ginseng and Astragalus Strong Bone Pill

目的观察参芪壮骨丸治疗脾胃气虚型骨质疏松症的临床疗效。方法将2014年2月—2015年6月间于该科住院的60例老年骨质疏松症患者随机分为对照组及治疗组各30例,对照组采用碳酸钙D3片口服,1粒/次,1次/d;治疗组在对照组基础上加服参芪壮骨丸,9 g/次,2次/d。治疗前及治疗后6个月进行骨密度测定及中医症状积分评定。结果治疗组总有效率为83.33%,对照组总有效率为60.00%,两组比较差异有统计学意义(P<0.05)。治疗组治疗后骨密度T值提高明显高于对照组,差异有统计学意义(P<0.05)。结论参芪壮骨丸治疗脾胃气虚型骨质疏松症有较好的疗效。

Objective To observe the Ginseng and astragalus strong bone pill clinical effect for the treatment of Spleen and stomach qi deficiency type Osteoporosis. Methods The February 2014 to June 2015 in our department in the hospital of 60 patients with senile osteoporosis were randomly divided into control group and treatment group 30 cases each,the control group oral calcium carbonate D3,1 pill/day,treatment group based on control group treatment and Ginseng and astragalus strong bone pill,9 grams each time,twice a day. bone mineral density measurement and TCM symptom integral evaluation before and after treatment Six months. Results The treatment group total effective rate83.33%,The control group total effective rate 60.00%（P〈0.05）,two groups effect comparison difference was statistically significant（P 〈 0.05）. Bone density after treatment by treatment group was obviously higher than that of control group,the difference was statistically significant（P 〈 0.05）. Conclusion The treatment of Spleen and stomach qi deficiency type Osteoporosis by Ginseng and astragalus strong bone pill has clinical effect.